Eli Lilly Dodges 2nd Cymbalta Label Class Cert. Bid

A California federal judge on Tuesday for a second time refused to certify a proposed class of consumers who claim Eli Lilly & Co. concealed the withdrawal risks associated with its...

Already a subscriber? Click here to view full article